Sami Inkinen

And I guess the punchline is the more insulin resistant you are, the more of that dose, the better is basically without sharing all of our secrets. But it's fascinating because we literally have dose response curves and it kind of tells us tells the story.

And I guess the punchline is the more insulin resistant you are, the more of that dose, the better is basically without sharing all of our secrets. But it's fascinating because we literally have dose response curves and it kind of tells us tells the story.

And I guess the punchline is the more insulin resistant you are, the more of that dose, the better is basically without sharing all of our secrets. But it's fascinating because we literally have dose response curves and it kind of tells us tells the story.

The other thing I wanted to add, Mark, when I listened to you and I was thinking those patient outcomes and what you had seen, if I wasn't, if I did not have the 10 year history of building Virta and seeing exactly the same results now with 100,000 plus Americans, I would still be like, oh, I'm sure nutrition can work, but

The other thing I wanted to add, Mark, when I listened to you and I was thinking those patient outcomes and what you had seen, if I wasn't, if I did not have the 10 year history of building Virta and seeing exactly the same results now with 100,000 plus Americans, I would still be like, oh, I'm sure nutrition can work, but

The other thing I wanted to add, Mark, when I listened to you and I was thinking those patient outcomes and what you had seen, if I wasn't, if I did not have the 10 year history of building Virta and seeing exactly the same results now with 100,000 plus Americans, I would still be like, oh, I'm sure nutrition can work, but

come on, these are the grandfather who was 100 pounds overweight and then ran a marathon. We always hear these stories. Like, oh, it's a one anomaly, one out of a million. But I think really what the world needs to hear, this is individuals, business decision makers, policy decision makers, scientists, is that These results are systematically possible. Absolutely systematically possible.

come on, these are the grandfather who was 100 pounds overweight and then ran a marathon. We always hear these stories. Like, oh, it's a one anomaly, one out of a million. But I think really what the world needs to hear, this is individuals, business decision makers, policy decision makers, scientists, is that These results are systematically possible. Absolutely systematically possible.

come on, these are the grandfather who was 100 pounds overweight and then ran a marathon. We always hear these stories. Like, oh, it's a one anomaly, one out of a million. But I think really what the world needs to hear, this is individuals, business decision makers, policy decision makers, scientists, is that These results are systematically possible. Absolutely systematically possible.

And this idea that we have 200 million sick American adults, metabolically unhealthy, and the best we can do is manage symptoms with medications is ridiculous. It is so ridiculous. And so we really have to get the message across that there is a way, nutritionally, you don't have to be a superman or superwoman. ordinary person, there's a systematic way to achieve those results.

And this idea that we have 200 million sick American adults, metabolically unhealthy, and the best we can do is manage symptoms with medications is ridiculous. It is so ridiculous. And so we really have to get the message across that there is a way, nutritionally, you don't have to be a superman or superwoman. ordinary person, there's a systematic way to achieve those results.

And this idea that we have 200 million sick American adults, metabolically unhealthy, and the best we can do is manage symptoms with medications is ridiculous. It is so ridiculous. And so we really have to get the message across that there is a way, nutritionally, you don't have to be a superman or superwoman. ordinary person, there's a systematic way to achieve those results.

Obviously, it's a distribution. Some are hugely successful in terms of moderately successful, but that message hasn't broken through yet. And it has to. And that's why I'm grateful to be on this podcast too, because it's ridiculous. There's no other way out of this metabolic health mess. GLB once in tap water is not going to solve this mess.

Obviously, it's a distribution. Some are hugely successful in terms of moderately successful, but that message hasn't broken through yet. And it has to. And that's why I'm grateful to be on this podcast too, because it's ridiculous. There's no other way out of this metabolic health mess. GLB once in tap water is not going to solve this mess.

Obviously, it's a distribution. Some are hugely successful in terms of moderately successful, but that message hasn't broken through yet. And it has to. And that's why I'm grateful to be on this podcast too, because it's ridiculous. There's no other way out of this metabolic health mess. GLB once in tap water is not going to solve this mess.

Yeah, absolutely. And first, upfront, I want to say that this may sound like, oh, this guy is so anti-pharmaceutical. No, I'm a physicist by training. I believe in science. I believe in Western medicine and also these GLP-1 drugs. you know, first one was, I think in America approved for treating type two diabetes 2005. And it's a tool in a toolkit.

Yeah, absolutely. And first, upfront, I want to say that this may sound like, oh, this guy is so anti-pharmaceutical. No, I'm a physicist by training. I believe in science. I believe in Western medicine and also these GLP-1 drugs. you know, first one was, I think in America approved for treating type two diabetes 2005. And it's a tool in a toolkit.

Yeah, absolutely. And first, upfront, I want to say that this may sound like, oh, this guy is so anti-pharmaceutical. No, I'm a physicist by training. I believe in science. I believe in Western medicine and also these GLP-1 drugs. you know, first one was, I think in America approved for treating type two diabetes 2005. And it's a tool in a toolkit.

It is a tool in a toolkit for type two diabetes and in some cases for obesity. So I just want to be very clear. And obviously Virta, Our providers practice evidence-based medicine. So anything I say next isn't going to be like, oh, you know, drugs are bad in all cases. No, that is not the case. But to answer your question specifically, and this is all data that's published in peer reviews.

It is a tool in a toolkit for type two diabetes and in some cases for obesity. So I just want to be very clear. And obviously Virta, Our providers practice evidence-based medicine. So anything I say next isn't going to be like, oh, you know, drugs are bad in all cases. No, that is not the case. But to answer your question specifically, and this is all data that's published in peer reviews.